News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
YVER ANTOINE
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/02/2023 |
4
| YVER ANTOINE (EVP & Chairman of Development) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns:
| Sold 6,500 shares
@ $4.4537, valued at
$28.9k
|
|
05/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/04/2023 |
4
| YVER ANTOINE (EVP & Chairman of Development) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns:
| Paid exercise price by delivering 3,615 shares
@ $3.9, valued at
$14.1k
Sold 6,700 shares
@ $3.691, valued at
$24.7k
|
|
02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/13/2023 |
4
| YVER ANTOINE (EVP & Chairman of Development) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns:
| Paid exercise price by delivering 7,732 shares
@ $4.25, valued at
$32.9k
|
|
01/04/2023 |
4
| YVER ANTOINE (EVP & Chairman of Development) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns:
| Paid exercise price by delivering 2,268 shares
@ $3.1, valued at
$7k
Sold 6,970 shares
@ $3.1759, valued at
$22.1k
|
|
12/05/2022 |
4
| YVER ANTOINE (EVP & Chairman of Development) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns:
| Sold 9,400 shares
@ $3.9089, valued at
$36.7k
|
|
11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/04/2022 |
4
| YVER ANTOINE (EVP & Chairman of Development) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns:
| Sold 2,468 shares
@ $4.0674, valued at
$10k
Sold 12,524 shares
@ $3.9167, valued at
$49.1k
|
|
09/02/2022 |
4
| YVER ANTOINE (EVP & Chairman of Development) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns:
| Sold 10,423 shares
@ $4.4121, valued at
$46k
|
|
08/03/2022 |
4
| YVER ANTOINE (EVP & Chairman of Development) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns:
| Sold 10,423 shares
@ $4.4522, valued at
$46.4k
|
|
07/20/2022 |
4
| YVER ANTOINE (EVP & Chairman of Development) has filed a Form 4 on Centessa Pharmaceuticals plc
Txns:
| Sold 20,000 shares
@ $4.8656, valued at
$97.3k
|
|
07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|